| 1 |
Cillóniz C, Torres A, Niederman MS. Management of pneumonia in critically ill patients[J]. BMJ, 2021, 375: e065871.
|
| 2 |
Baek MS, Park S, Choi JH, et al. Mortality and prognostic prediction in very elderly patients with severe pneumonia[J]. J Intensive Care Med, 2020, 35(12): 1405-1410.
|
| 3 |
Bateman RM, Sharpe MD, Jagger JE, et al. 36th international symposium on intensive care and emergency medicine: Brussels, Belgium. 15-18 March 2016[J]. Crit Care, 2016, 20(Suppl 2): 94.
|
| 4 |
Kesmez Can F, Özkurt Z, Öztürk N, et al. Effect of IL-6, IL-8/CXCL8, IP-10/CXCL 10 levels on the severity in COVID 19 infection[J]. Int J Clin Pract, 2021, 75(12): e14970.
|
| 5 |
Sayah W, Berkane I, Guermache I, et al. Interleukin-6, procalcitonin and neutrophil-to-lymphocyte ratio: Potential immune-inflammatory parameters to identify severe and fatal forms of COVID-19[J]. Cytokine, 2021, 141: 155428.
|
| 6 |
Zhang LS, Ling PY, Chen Y, et al. [Progress in the effect of human epididymis protein 4 on sperm maturation][J]. Zhonghua Yu Fang Yi Xue Za Zhi, 2022, 56(8): 1123-1126.
|
| 7 |
Huang X, Guo X, Yan G, et al. Dapagliflozin attenuates contrast-induced acute kidney injury by regulating the HIF-1α/HE4/NF-κB Pathway[J]. J Cardiovasc Pharmacol, 2022, 79(6): 904-913.
|
| 8 |
中国医师协会急诊医师分会. 中国急诊重症肺炎临床实践专家共识[J]. 中国急救医学，2016, 36(2): 11.
|
| 9 |
Ferreira-Coimbra J, Tejada S, Campogiani L, et al. Levels of evidence supporting European and American community-acquired pneumonia guidelines[J]. Eur J Clin Microbiol Infect Dis, 2020, 39(6): 1159-1167.
|
| 10 |
Bijlsma MW, Brouwer MC, Kasanmoentalib ES, et al. Community-acquired bacterial meningitis in adults in the Netherlands, 2006-14: a prospective cohort study[J]. Lancet Infect Dis, 2016, 16(3): 339-347.
|
| 11 |
Ren Q, Liu H, Wang Y, et al. The role of red blood cell distribution width in the severity and prognosis of community-acquired pneumonia[J]. Can Respir J, 2021, 2021: 8024024.
|
| 12 |
Song Y, Yang J, Sun H, et al. Serum levels of sirtuin 6 are associated with severe community acquired pneumonia in children: An observational study[J]. Cir Cir, 2022, 90(5): 632-637.
|
| 13 |
Kühnapfel A, Horn K, Klotz U, et al. Genetic regulation of cytokine response in patients with acute community-acquired pneumonia[J]. Genes (Basel), 2022, 13(1): 111.
|
| 14 |
陈晓珊. 血清PCT、RAGE、sTREM-1表达水平与重症肺炎患者病情严重程度及预后的关系[J]. 标记免疫分析与临床，2020, 27(1): 136-141.
|
| 15 |
Sun ML, Yang ZY, Wu QJ, et al. The role of human epididymis protein 4 in the diagnosis and prognosis of diseases: An umbrella review of systematic reviews and Meta-analyses of observational studies[J]. Front Med (Lausanne), 2022, 9: 842002.
|
| 16 |
Sütö R, Pócsi M, Szabó Z, et al. Elevated level of serum human epididymis protein 4 (HE4) predicts disease severity and mortality in COVID-19 pneumonia[J]. BMC Pulm Med, 2023, 23(1): 512.
|
| 17 |
Wang J, Zhao H, Xu F, et al. Human epididymis protein 4 (HE4) protects against cystic pulmonary fibrosis associated-inflammation through inhibition of NF-κB and MAPK singnaling[J]. Genes Genomics, 2019, 41(9): 1045-1053.
|
| 18 |
Luo J, Liang J, Wang S, et al. Serum human epididymis secretory protein 4 correlates with sepsis-associated acute respiratory distress syndrome and 28-day mortality in critically ill patients[J]. Ann Clin Biochem, 2022, 59(5): 338-346.
|
| 19 |
Raghu G, Richeldi L, Jagerschmidt A, et al. Idiopathic pulmonary fibrosis: Prospective, case-controlled study of natural history and circulating biomarkers[J]. Chest, 2018, 154(6): 1359-1370.
|
| 20 |
Saleem N, Kulkarni A, Snow T, et al. Effect of corticosteroids on mortality and clinical cure in community-acquired pneumonia: A systematic review, Meta-analysis, and Meta-regression of randomized control trials[J]. Chest, 2023, 163(3): 484-497.
|
| 21 |
Zhang C, He H, Chen X, et al. The prediction of lymphocyte count and neutrophil count on the efficacy of Xuebijing adjuvant treatment for severe community-acquired pneumonia: A post hoc analysis of a randomized controlled trial[J]. Phytomedicine, 2023, 110: 154614.
|
| 22 |
Ge YL, Zhang HF, Zhang Q, et al. Neutrophil-to-lymphocyte ratio in adult community-acquired pneumonia patients correlates with unfavorable clinical outcomes[J]. Clin Lab, 2019, 65(5): doi: 10.7754/Clin.Lab.2018.181042.
|
| 23 |
Kuikel S, Pathak N, Poudel S, et al. Neutrophil-lymphocyte ratio as a predictor of adverse outcome in patients with community-acquired pneumonia: A systematic review[J]. Health Sci Rep, 2022, 5(3): e630.
|
| 24 |
马晓迪，刘振宁. 中性粒细胞/淋巴细胞比值对重症急性胰腺炎病情严重程度及预后评估价值的研究进展[J]. 中国实用内科杂志，2023, 43(6): 518-521.
|
| 25 |
Meng Y, Zhang L, Huang M, et al. Blood heparin-binding protein and neutrophil-to-lymphocyte ratio as indicators of the severity and prognosis of community-acquired pneumonia[J]. Respir Med, 2023, 208: 107144.
|
| 26 |
Xiao X, Hong Y, Wang S, et al. Diagnostic value of plasma heparin-binding protein and the heparin-binding protein-to-albumin ratio in patients with community-acquired Pneumonia: a retrospective study[J]. BMC Infect Dis, 2023, 23(1): 777.
|
| 27 |
刘晓燕，张小佛，李 嘉，等. 肝素结合蛋白对儿童重症腺病毒肺炎的诊断价值[J]. 中国当代儿科杂志，2022, 24(9): 1014-1019.
|